Astral Systems raises £23m Series A to scale multi-state nuclear fusion technology for medical radioisotopes

Bristol-based deep tech firm Astral Systems has raised £23m in Series A funding led by Mercia Ventures. The company has developed and commercialised a multi-state fusion technology, a novel form of nuclear fusion aimed at addressing fragile supply chains and potential global shor